insights_auto
Mtazamo: Thamani itaongezeka kwa asilimia 52.0·Thamani itapungua kwa asilimia 6.9
Nenda kwenye kichupo cha uchanganuzichevron_right
AMGN:NASDAQ
Amgen Inc
US$ 460.42
arrow_upward
+0.03%(+0.14) Siku 1
6 Nov, 16:00:01 GMT -5 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya AMGN...
Fungua
US$ 448.16
Juu
US$ 462.91
Chini
US$ 447.04
Mtaji wa soko
249.09B
Wastani wa kiasi cha mauzo
2.83M
Kiasi cha mauzo ya hisa
0.00
Gawio
2.19%
Mgawo wa faida wa kila robo mwaka
US$ 2.52
Tarehe ya kutojumuisha gawio
21 Ago 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
26.70
Juu kwa wiki 52
US$ 483.99
Chini kwa wiki 52
US$ 312.53
EPS
US$ 17.25
Beta
0.43
Hisa za wawekezaji
540.91M
Idadi ya wafanyakazi
elfu 32
Fungua
US$ 448.16
Juu
US$ 462.91
Chini
US$ 447.04
Mtaji wa soko
249.09B
Wastani wa kiasi cha mauzo
2.83M
Kiasi cha mauzo ya hisa
0.00
Gawio
2.19%
Mgawo wa faida wa kila robo mwaka
US$ 2.52
Tarehe ya kutojumuisha gawio
21 Ago 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
26.70
Juu kwa wiki 52
US$ 483.99
Chini kwa wiki 52
US$ 312.53
EPS
US$ 17.25
Beta
0.43
Hisa za wawekezaji
540.91M
Idadi ya wafanyakazi
elfu 32
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
24/7 Wall St.
·
saa 15 zilizopita
Amgen’s Dividend Has Grown 800% Since 2011. Here’s What It Pays Today
CNBC
·
mwezi 1 uliopita
Stocks making the biggest moves midday: Lennar, Capri, Vicor, Amgen & more
Wasifu
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Kuhusu Amgen Inc
Afisa Mkuu Mtendaji (CEO)Robert A. Bradway
Wafanyakazielfu 31.5
Lilianzishwa1980
Makao makuuThousand Oaks, California, Marekani
SektaHealth Care
Sekta-
Tovutiamgen.com